CAPN1 gives your body instructions for making calpain 1, a protein that helps nerve cells and muscles adjust, repair, and send signals. If the CAPN1 gene does not work properly, movement can become harder over time, often with leg stiffness, weakness, balance problems, or an unusual walking pattern. Certain pathogenic variants in the CAPN1 gene are linked to inherited conditions such as hereditary spastic paraplegia, and some people also have speech or coordination changes.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for making proteins, the parts of cells that do the work. Others mostly help control when certain processes happen, where they take place, and how strongly they are carried out. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. To go deeper into this topic, you can find more in the LearnHub.
Overview
CAPN1Gene function
What if the gene works
The CAPN1 gene helps make calpain-1, an enzyme that trims other proteins when calcium signals arrive. This helps your cells adjust their shape, send signals, and recycle worn proteins.
Risk
What if the gene does not work
People with two nonworking variants in the CAPN1 gene often develop progressive leg stiffness and weakness, sometimes with balance or coordination problems. Milder and more severe variants can influence when symptoms begin and how much the nervous system is affected.
Treatment
What does that mean for your treatment
No CAPN1-specific treatment or drug selection approach is currently established. Care is based on the person’s symptoms rather than the specific CAPN1 variant. The CAPN1 gene is being studied in brain and nerve disease research, but this has not yet changed routine treatment.
Conditions associated with CAPN1
Gene function
What if the gene works
Inside your cells, the CAPN1 gene helps make a protein called calpain 1. This protein acts like a careful pair of scissors that trims selected proteins when calcium levels rise for a short time. That controlled trimming helps cells adjust their shape, signals, and internal organization during everyday activity.
CAPN1 makes controlled cuts in selected proteins instead of breaking them down completely. This targeted trimming helps cells respond to brief calcium signals and adjust how other proteins work.
Calpain 1 helps remodel the cell’s inner support framework, which gives cells shape and flexibility. That allows routine changes in attachment, spreading, and movement during everyday cell activity.
After a calcium message arrives, CAPN1 can trim signaling proteins so the response stays measured. This fine tuning is part of how the CAPN1 gene works in the body from moment to moment.
By clipping parts of larger protein groups, CAPN1 helps cells take apart and rebuild worn pieces. This supports normal protein recycling and keeps cell machinery adaptable.
What is a variant?
A genetic variant is a slight difference in the DNA sequence within a gene. These differences are common and help shape normal human diversity, including differences in appearance, metabolism, and the way the body reacts to environmental influences. Many variants do not lead to any noticeable effects and are simply part of natural genetic variation. At times, though, a variant can change how a gene works more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CAPN1 gene can reduce or switch off the calpain-1 protein by altering its shape, making it unstable, or disrupting the part that responds to calcium. This is how variants influence the CAPN1 gene's function in cells. Some changes leave a little activity, while more severe variants often remove protein activity almost completely and are linked to earlier or more marked movement symptoms in hereditary spastic paraplegia caused by CAPN1 variants.
How variants are linked to conditions
Pathogenic variants in the CAPN1 gene cause hereditary spastic paraplegia type 76, often called CAPN1-related hereditary spastic paraplegia. This condition usually leads to gradually increasing leg stiffness and weakness, and some people also have balance problems, coordination changes, or speech difficulties. Age at onset and symptom pattern can vary, even within families.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common across the general population. Most have no direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when more than one gene and environmental factors are involved. In some situations, though, one well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For CAPN1-related conditions, risk is mainly shaped by inheritance rather than lifestyle. The chance is highest when both biological parents carry a disease-causing change in the CAPN1 gene, because a child can inherit two changed copies. There is no broadly confirmed evidence that diet, exercise, or other everyday factors meaningfully change this genetic risk.
Inheritance of CAPN1 variants
CAPN1-related conditions are inherited in an autosomal recessive pattern. In practical terms, how CAPN1 variants are inherited usually means a child receives one changed copy of the CAPN1 gene from each parent, and the parents are often healthy carriers. When both parents carry a CAPN1 variant, each pregnancy has a 25% chance of a child with the condition, a 50% chance of a child who is also a carrier, and a 25% chance of a child who inherits neither variant. Because the CAPN1 gene is on an autosome, this pattern affects sons and daughters equally.
What does my CAPN1 result mean for my family?
For CAPN1, the best-known family pattern is recessive, which usually means parents are healthy carriers and brothers or sisters may also be carriers or, less often, affected. Close relatives may want to learn whether the same gene change runs in the family, especially if there is a history of walking stiffness, balance problems, or similar nerve symptoms. Children of someone with a CAPN1-related condition are usually carriers unless the other parent also carries a CAPN1 change.
Genetic information
Genetic testing
How you find out about variants
Variants in the CAPN1 gene are found with genetic testing for CAPN1 variants, usually using a blood or saliva sample. A lab reads your DNA and compares the CAPN1 gene with the usual sequence to look for changes. Results may show a harmful variant, a harmless variant, or a finding that is still unclear.
When should I consider getting a genetic test?
Consider CAPN1 genetic testing if you or your child has ongoing leg stiffness, muscle weakness, balance trouble, or a walking pattern that suggests an inherited nerve condition, especially if similar problems run in the family. Testing can help confirm whether CAPN1 is the cause and clarify family risk.
A genetic result is only one part of your health story
Genetic results can provide useful insight, but how much they reveal varies based on the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, also shape how the body functions. In some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is most helpful when viewed alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Two people can take the same treatment and have different results because their bodies may break down, transport, or react to a drug in slightly different ways. These common inherited differences can influence how well a medicine works or how sensitive someone is to side effects.
What is Pharmacogenetics?
Pharmacogenetics looks at how genetic differences can shape a person’s response to medications. It examines links between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes can affect both how strongly a drug works and how the body processes it. This information can help support treatment decisions that are more informed and more individualized. You can read more about this topic in the LearnHub.
Drugs influenced by the CAPN1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices. If you have medication side effects, are starting a new treatment, or have questions about how your medicines may affect you, talk with your doctor or pharmacist.
History
Research on the CAPN1 gene grew out of studies in the late 1960s and 1970s on calcium activated protein cutting enzymes in animal tissues. The enzyme now linked to the CAPN1 gene was first known as μ-calpain, a name based on the small amount of calcium needed for its activity in lab experiments. As medical science evolved, so did understanding of this gene. In the following decades, researchers separated CAPN1 from related calpain family members and mapped its place in the human genome. Interest in the CAPN1 gene increased further when inherited variants were identified in some families with a form of hereditary spastic paraplegia, helping connect earlier lab findings with a human neurologic condition.